• 中国科技期刊卓越行动计划项目资助期刊
  • 中国精品科技期刊
  • EI
  • Scopus
  • CAB Abstracts
  • Global Health
  • 北大核心期刊
  • DOAJ
  • EBSCO
  • 中国核心学术期刊RCCSE A+
  • 中国科技核心期刊CSTPCD
  • JST China
  • FSTA
  • 中国农林核心期刊
  • 中国开放获取期刊数据库COAJ
  • CA
  • WJCI
  • 食品科学与工程领域高质量科技期刊分级目录第一方阵T1
中国精品科技期刊2020
钟诚,罗均匀,马文聪,等. 广佛手多糖体外发酵对降血糖活性和肠道菌群的影响及其结构变化[J]. 食品工业科技,2025,46(15):1−13. doi: 10.13386/j.issn1002-0306.2024080004.
引用本文: 钟诚,罗均匀,马文聪,等. 广佛手多糖体外发酵对降血糖活性和肠道菌群的影响及其结构变化[J]. 食品工业科技,2025,46(15):1−13. doi: 10.13386/j.issn1002-0306.2024080004.
ZHONG Cheng, LUO Junyun, MA Wencong, et al. Effects of in Vitro Fermentation of Citrus medica var. sarcodactylis Polysaccharides on Hypoglycemic Activity, Gut Microbiota and Structural Alterations[J]. Science and Technology of Food Industry, 2025, 46(15): 1−13. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024080004.
Citation: ZHONG Cheng, LUO Junyun, MA Wencong, et al. Effects of in Vitro Fermentation of Citrus medica var. sarcodactylis Polysaccharides on Hypoglycemic Activity, Gut Microbiota and Structural Alterations[J]. Science and Technology of Food Industry, 2025, 46(15): 1−13. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2024080004.

广佛手多糖体外发酵对降血糖活性和肠道菌群的影响及其结构变化

Effects of in Vitro Fermentation of Citrus medica var. sarcodactylis Polysaccharides on Hypoglycemic Activity, Gut Microbiota and Structural Alterations

  • 摘要: 本文以纯化获得的广佛手多糖(FCP-2-1)为研究对象,探究其体外模拟消化特性以及体外发酵对其降血糖活性、调控肠道菌群和短链脂肪酸的影响,并对其体外发酵降解物的结构进行分析。结果表明,经体外模拟消化后,FCP-2-1的分子量无显著变化。FCP-2-1体外发酵8 h降解物(DFPG-8)具有良好的α-淀粉酶和α-葡萄糖苷酶活性抑制率(51.73%和55.67%),分别比发酵前提高了11.37%和17.57%。此外,经体外发酵8 h后,FCP-2-1可降低厚壁菌门(Firmicutes)与拟杆菌门(Bacteroidetes)的丰度比值(F/B),提高真杆菌属(Eubacterium_eligens_group)、普拉梭菌属(Faecalibaterium)以及双歧杆菌属(Bifidobacterium)等益生菌的相对丰度,并显著提高乙酸、丙酸和正丁酸含量。结构分析表明,与未发酵的FCP-2-1(DFPG-0)相比,DFPG-8的平均直径降低,表面被肠道菌群分解,形成更为粗糙表面结构;分子量从1.503×104 Da降解为1891 Da;单糖组成由阿拉伯糖、半乳糖、半乳糖醛酸(0.342:0.280:0.276)转变为阿拉伯糖、半乳糖、半乳糖醛酸和鼠李糖(0.117:0.208:0.326:0.123);FT-IR分析发现其存在αβ构型,并且1735 cm−1处吸收峰明显减弱。上述结果说明,FCP-2-1不会在胃肠道被消化,但可被肠道菌群利用,经肠道菌群利用后所产生的降解物结构发生变化且具有更好的降血糖活性。

     

    Abstract: This study focused on the purified polysaccharide FCP-2-1 isolated from Citrus medica var. sarcodactylis (Buddha’s hand) to investigate its in vitro simulated digestion characteristics, as well as the effects of in vitro fermentation on its hypoglycemic activity, modulation of gut microbiota, and production of short-chain fatty acids (SCFAs). The structure of its fermentation degradation products was also analyzed. The results indicated that the molecular weight of FCP-2-1 did not exhibit significant changes after in vitro simulated digestion. Degradation products of FCP-2-1 fermented for 8 hours by gut microbiota (DFPG-8) displayed strong inhibitory effects on α-amylase and α-glucosidase activities, with inhibition rates of 51.73% and 55.67%, representing increases of 11.37% and 17.57% respectively compared to the pre-fermentation stage. Additionally, following 8 hours of in vitro fermentation, FCP-2-1 was able to reduce the Firmicutes/Bacteroidetes (F/B) ratio, while increasing the relative abundance of beneficial bacteria such as Eubacterium_elites_group, Faecalibacterium and Bifidobacterium. Furthermore, there was a significant increase in the concentrations of acetic acid, propionic acid, and butyric acid. Structural analysis revealed that, compared to the unfermented FCP-2-1 (DFPG-0), DFPG-8 exhibited a reduced average molecular diameter and its surface morphology became rougher, likely due to microbial degradation. The molecular weight was reduced from 1.503×104 Da to 1891 Da. The composition monosaccharides were altered from arabinose, galactose, and galacturonic acid (0.342:0.280:0.276) to arabinose, galactose, galacturonic acid, and rhamnose (0.117:0.208:0.326:0.123). FT-IR spectroscopy revealed both α- and β- configurations in the polysaccharide, and a notable attenuation of the absorption peak at 1735 cm−1. These findings suggest that FCP-2-1 is resistant to digestion in the gastrointestinal tract, but is fermented by gut microbiota, resulting in structural modifications and enhanced hypoglycemic potential.

     

/

返回文章
返回